Clover Biopharmaceuticals, Ltd. (HKG:2197)
0.2650
+0.0100 (3.92%)
Jun 23, 2025, 4:08 PM HKT
Clover Biopharmaceuticals Market Cap
Clover Biopharmaceuticals has a market cap or net worth of 330.75 million as of June 23, 2025. Its market cap has decreased by -37.80% in one year.
Market Cap
330.75M
Enterprise Value
-16.57M
Revenue
40.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.27
Market Cap Chart
Since November 5, 2021, Clover Biopharmaceuticals's market cap has decreased from 15.03B to 330.75M, a decrease of -97.80%. That is a compound annual growth rate of -65.11%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 20, 2025 | 330.75M | 5.81% |
Dec 31, 2024 | 312.59M | -61.08% |
Dec 29, 2023 | 803.26M | -76.01% |
Dec 30, 2022 | 3.35B | -78.71% |
Dec 31, 2021 | 15.73B | 4.62% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeOne Medicines | 230.13B |
Hansoh Pharmaceutical Group Company | 166.48B |
Innovent Biologics | 128.33B |
JD Health International | 126.72B |
WuXi Biologics | 98.06B |
Sino Biopharmaceutical | 89.24B |
CSPC Pharmaceutical Group | 87.10B |
Akeso | 81.95B |